Age-related macular degeneration (AMD) is the leading cause of vision loss, affecting more than 10 million Americans — more than cataracts and glaucoma combined. AMD is the deterioration of the macula, the small central area of the retina that controls visual acuity.
Western medicine offers no cure for AMD. However, AcuNova, a widely used protocol in Europe, was developed by John Boel of Denmark. AcuNova is a type of acupuncture treatment that has shown remarkable results for people who have been medically diagnosed with degenerative eye disorders. About 80 percent of patients have experienced increased brightness, better acuity and a larger visual field after just 10 treatments.
Treatment involves placing acupuncture needles on points in or around specific joints of the hands and feet (not in the eyes). It is thought that these needles generate a frequency that affects areas of the brain responsible for vision. Blood flow is increased to both the optic nerve and the retinal structure of the eye. This aids in “waking up” dormant neuronal cells that have become “unhealthy” over a period of time.
The average patient starts with two sessions per day for five days over a two-week period, for a total of 20 treatments. Maintenance treatments then are staggered as needed.